| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11010-013-1678-7 |
| P698 | PubMed publication ID | 23681423 |
| P50 | author | Mohammad Ali Shokrgozar | Q42604344 |
| Kayhan Azadmanesh | Q54318606 | ||
| Amir Amanzadeh | Q59153464 | ||
| Behnaz Bakhshandeh | Q83429786 | ||
| Najmeh Ranji | Q85321700 | ||
| P2093 | author name string | Majid Sadeghizadeh | |
| Morteza Karimipour | |||
| P2860 | cites work | miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy | Q21245464 |
| IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation | Q24629447 | ||
| MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression | Q24643470 | ||
| The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition | Q24646324 | ||
| DNA array analysis of interleukin-2-regulated immediate/early genes | Q24799770 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling | Q28141157 | ||
| The role of let-7 in cell differentiation and cancer | Q28259549 | ||
| MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation | Q28269643 | ||
| mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 | ||
| Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling | Q28297583 | ||
| microRNA target predictions in animals | Q29616081 | ||
| MicroRNA control in the immune system: basic principles | Q29618112 | ||
| CD4+ T cell-derived IL-2 signals during early priming advances primary CD8+ T cell responses | Q33515660 | ||
| IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation | Q33977594 | ||
| miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma | Q34219872 | ||
| miR-93 suppresses proliferation and colony formation of human colon cancer stem cells | Q34241503 | ||
| Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer | Q34536176 | ||
| It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. | Q34754748 | ||
| Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus | Q35134056 | ||
| Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation | Q35553324 | ||
| Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. | Q35901256 | ||
| The role of suppressors of cytokine signalling in thymopoiesis and T cell activation | Q36132892 | ||
| miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells | Q36322395 | ||
| OncomiRs: the discovery and progress of microRNAs in cancers | Q36951319 | ||
| Micromanagement of the immune system by microRNAs | Q37060274 | ||
| A role for microRNAs in the development of the immune system and in the pathogenesis of cancer | Q37091383 | ||
| microRNAs and the immune response | Q37178538 | ||
| Regulation of phosphoinositide 3-kinase expression in health and disease | Q37418463 | ||
| The role of CD4 T cell help for CD8 CTL activation | Q37467654 | ||
| Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | Q38324435 | ||
| Transcriptional program of apoptosis induction following interleukin 2 deprivation: identification of RC3, a calcium/calmodulin binding protein, as a novel proapoptotic factor | Q38353570 | ||
| A microRNA signature associated with chondrogenic lineage commitment. | Q39559528 | ||
| MicroRNA signature associated with osteogenic lineage commitment. | Q39650412 | ||
| Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis. | Q40102948 | ||
| CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. | Q40761126 | ||
| Induction of IL-1 beta-converting enzyme-independent apoptosis by IL-2 in human T cell lines | Q41089615 | ||
| The kinases MEKK2 and MEKK3 regulate transforming growth factor-β-mediated helper T cell differentiation. | Q41840327 | ||
| Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors | Q42833178 | ||
| Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase | Q43842315 | ||
| IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells | Q44394226 | ||
| CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. | Q46897630 | ||
| An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. | Q51888571 | ||
| Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. | Q52007151 | ||
| Prolonged costimulation is required for naive T cell activation. | Q53618377 | ||
| Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells. | Q54312185 | ||
| CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes | Q57956197 | ||
| Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells | Q77419032 | ||
| Nadir CD4+ T Cell Count Predicts Response to Subcutaneous Recombinant Interleukin-2 | Q79109398 | ||
| Human activated CD4+ T lymphocytes increase IL-2 expression by downregulating microRNA-181c | Q82637413 | ||
| Comparison of gene expression profiles in mouse primary T cells under normal and prolonged activation | Q83894055 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 229-238 | |
| P577 | publication date | 2013-05-17 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | MiR-17-92 cluster: an apoptosis inducer or proliferation enhancer | |
| P478 | volume | 380 |
| Q35083572 | AKT family and miRNAs expression in IL-2 induced CD4(+)T cells |
| Q96135933 | Apoptosis induction and proliferation inhibition by silibinin encapsulated in nanoparticles in MIA PaCa-2 cancer cells and deregulation of some miRNAs |
| Q35475974 | Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer |
| Q51275379 | Circulating MicroRNA Are Predictive of Aging and Acute Adaptive Response to Resistance Exercise in Men. |
| Q36553118 | Deregulation of miR-21 and miR-155 and their putative targets after silibinin treatment in T47D breast cancer cells |
| Q36291392 | Differential Sensitivity of Target Genes to Translational Repression by miR-17~92. |
| Q38891898 | Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines. |
| Q33814852 | MicroRNA-17~92 is required for nephrogenesis and renal function |
| Q58563248 | MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation |
| Q49966404 | Potential Role of MicroRNA in the Anabolic Capacity of Skeletal Muscle with Aging |
| Q36768990 | Silibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer Cells |
| Q64248970 | The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster |
Search more.